Research use only meaning: what does the label tell a Hanoi buyer?

The compounds are sold as research materials. They are not approved medicines. This site does not suggest any use in people, and it never says how much of anything to use. Someone who orders here is buying a research compound and nothing more. Each photo shows the whole label: the shop name, the compound, the size and those three words.

Before any page was written, the research behind it was read, and it is not spread evenly. 24 of the 42 research notes cite a study in which people were given the compound, though in five of those the people received a related molecule, a single ingredient of a blend, or a mixed product instead, and the page says which. Two more, MOTS-c and Humanin, have studies in people that only measured the body's own levels. Fifteen pages cite nothing but cell, animal, lab or review papers; one of them, Epithalon, adds that one human study was found but gave too little detail to use. For one, Adamax, the search turned up no published study of the compound itself.

That spread is the practical reason for the label. For 18 of the 42, no page cites a study that gave the compound to people, and a shop cannot fill that gap.

For Five vials, the papers cited in their research notes record an approved medicine with the same ingredient, and each of those notes says so in its opening lines. This list follows the cited papers only; it is not a survey of every country's medicines. Prescription medicines approved in some countries carry tirzepatide as their active ingredient. A prescription medicine also uses tesamorelin as its active ingredient, and the three trials summarised on its page all enrolled adults living with HIV. SS-31 was given an accelerated approval in the United States in 2025, under its drug name elamipretide, for one rare inherited disease. PT-141, as bremelanotide, was approved there in 2019 for low sexual desire in premenopausal women. A 2007 review notes that thymosin alpha-1 is used as a medicine in several countries.

In every case what this shop sells is a research-grade vial, not the medicine, and nothing approves it for use in people. A sixth vial, retatrutide, is still in clinical trials and is approved nowhere. See the tirzepatide page for one example.

How much to use is a medical decision. It depends on the person, the product and the reason, and it belongs with a doctor who knows the person. The research notes describe what papers studied and what they measured, and they stop there on purpose: an amount lifted from a study is not advice for anyone.

Three habits keep the label honest across the shop. Each page opens with what the compound is and what it costs, never with a promise. Each research note names the type of study and its limits, and its sources sit at the end of the section, linked to PubMed: 131 papers across the 42 vial pages. And no page lends one compound's results to another. Adamax gets no Semax results, the Snap-8 page marks its evidence as Argireline's, and the TB-500 page keeps its own papers apart from those on thymosin beta-4. Facts kept for AI tools sit on the page for AI assistants.

If you have a question about your health, please speak to a doctor. A shop cannot answer it, and this one will not try. For questions about an order, see the delivery and ordering page or the contact page. How the research notes are chosen is set out on the about page.